Statistically Optimized Tacrolimus and Thymoquinone Co-Loaded Nanostructured Lipid Carriers Gel for Improved Topical Treatment of Psoriasis.
Box–Behnken design
nanostructured lipid carrier
psoriasis
tacrolimus
thymoquinone
topical delivery
Journal
Gels (Basel, Switzerland)
ISSN: 2310-2861
Titre abrégé: Gels
Pays: Switzerland
ID NLM: 101696925
Informations de publication
Date de publication:
25 Jun 2023
25 Jun 2023
Historique:
received:
11
06
2023
revised:
22
06
2023
accepted:
23
06
2023
medline:
28
7
2023
pubmed:
28
7
2023
entrez:
28
7
2023
Statut:
epublish
Résumé
The aim of this investigation was to develop and analyze a tacrolimus and thymoquinone co-loaded nanostructured lipid carriers (TAC-THQ-NLCs)-based nanogel as a new combinatorial approach for the treatment of psoriasis. The NLCs were formulated by an emulsification-solvent-evaporation technique using glyceryl monostearate, Capryol 90 (oil), and a mixture of Tween 80 and Span 20 as a solid lipid, liquid lipid, and surfactant, respectively. Their combination was optimized using a three-factor and three-level Box-Behnken design (3
Identifiants
pubmed: 37504393
pii: gels9070515
doi: 10.3390/gels9070515
pmc: PMC10379417
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Int J Pharm. 2007 Dec 10;345(1-2):163-71
pubmed: 17644288
Biochem Pharmacol. 2012 Feb 15;83(4):443-51
pubmed: 22005518
Free Radic Res. 2016 Jun;50(6):585-95
pubmed: 27098416
Drug Deliv Transl Res. 2021 Jun;11(3):1245-1260
pubmed: 32965640
Pharmacogn Mag. 2012 Oct;8(32):268-72
pubmed: 24082629
Int J Pharm. 2000 Apr 20;199(2):167-77
pubmed: 10802410
Drug Deliv. 2017 Nov;24(1):61-74
pubmed: 28155509
J Allergy Clin Immunol. 2017 Sep;140(3):645-653
pubmed: 28887948
Colloids Surf B Biointerfaces. 2020 Feb;186:110603
pubmed: 31846892
Indian Dermatol Online J. 2013 Oct;4(4):267-72
pubmed: 24350003
Indian J Dermatol Venereol Leprol. 2010 Nov-Dec;76(6):612-21
pubmed: 21079304
Int J Mol Sci. 2021 Oct 26;22(21):
pubmed: 34769005
Colloids Surf B Biointerfaces. 2013 Feb 1;102:822-32
pubmed: 23104039
Expert Opin Drug Deliv. 2016 Oct;13(10):1461-73
pubmed: 27164301
J Dermatolog Treat. 2017 Dec;28(8):702-708
pubmed: 28481664
Int J Pharm. 2021 Sep 25;607:121006
pubmed: 34391848
J Drug Target. 2017 Jan;25(1):58-74
pubmed: 27186665
Int J Pharm. 2017 Aug 7;528(1-2):511-523
pubmed: 28629978
Int J Pharm. 2019 May 1;562:96-104
pubmed: 30902706
BMC Complement Altern Med. 2019 Nov 27;19(1):334
pubmed: 31771651
PLoS One. 2014 Dec 29;9(12):e115952
pubmed: 25546392
Nanomedicine (Lond). 2020 May;15(12):1167-1187
pubmed: 32370601
Curr Drug Metab. 2020;21(14):1136-1143
pubmed: 32682366
Colloids Surf B Biointerfaces. 2018 Apr 1;164:281-290
pubmed: 29413607
Int J Pharm. 2010 Nov 30;401(1-2):93-102
pubmed: 20858539
Adv Drug Deliv Rev. 2002 Nov 1;54 Suppl 1:S131-55
pubmed: 12460720
Expert Opin Drug Deliv. 2014 Dec;11(12):1833-47
pubmed: 25078031
Eur J Pharm Sci. 2009 Jun 28;37(3-4):508-13
pubmed: 19406231
Expert Opin Drug Deliv. 2017 Feb;14(2):165-177
pubmed: 27882780
Expert Opin Drug Saf. 2020 Apr;19(4):489-498
pubmed: 31985309
Curr Drug Deliv. 2016;13(1):4-26
pubmed: 26279117
Int J Pharm. 2003 Nov 28;267(1-2):79-91
pubmed: 14602386
Nanotechnology. 2021 Jul 20;32(41):
pubmed: 34198267
J Pharm Sci. 2019 Oct;108(10):3382-3395
pubmed: 31201904
Int J Nanomedicine. 2010 Mar 09;5:117-28
pubmed: 20309398
Colloids Surf B Biointerfaces. 2014 Nov 1;123:610-5
pubmed: 25454755
Int J Biol Macromol. 2015 Jan;72:569-74
pubmed: 25220787
J Drug Target. 2022 Dec;30(10):1113-1134
pubmed: 35856926
Int J Pharm. 2007 Aug 1;340(1-2):198-206
pubmed: 17482778
Artif Cells Nanomed Biotechnol. 2018;46(sup1):15-31
pubmed: 29183147
Mol Pharm. 2013 Sep 3;10(9):3459-74
pubmed: 23927416
Int J Pharm. 2020 Sep 25;587:119705
pubmed: 32738456
Artif Cells Nanomed Biotechnol. 2016 Sep;44(6):1374-82
pubmed: 25919064
Eur J Pharm Biopharm. 2021 Jun;163:223-239
pubmed: 33864904
Pharmaceutics. 2022 Aug 25;14(9):
pubmed: 36145519
Expert Opin Pharmacother. 2010 Aug;11(12):1999-2009
pubmed: 20569091
Colloids Surf B Biointerfaces. 2017 Nov 1;159:23-29
pubmed: 28779637
J Pharm Sci. 2018 Nov;107(11):2914-2926
pubmed: 30076853